Miscellaneous

18
Mar

Genoskin collaboration with argenx

Genoskin & argenx showcasehuman-based NAM platformPress releaseGenoskin presents translational human-based NAM platform at SOT 2026 in collaboration with argenxAdvancing New Approach Methodologies (NAMs) with human skin modelsAt the 2026 annual meeting of the Society Of Toxicology (SOT), we will present new data demonstrating the value of our HypoSkin® ex vivo human skin platform as a translational human-based New Approach Methodology
Read more
3
Feb

Genoskin at AAAAI 2026

Conferences & eventsCome & meet our amazing teamGenoskin at The American Academy of Allergy, Asthma, & Immunology (AAAAI) Annual Meeting 2026Enabling non-clinical immune assessment through ex vivo human skin and mast cell models Genoskin was pleased to participate in the American Academy of Allergy, Asthma, & Immunology (AAAAI) Annual Meeting in Philadelphia, PA, one of the world’s leading scientific gatherings
Read more
19
Jan

Genoskin at SOT 2026

Conferences & eventsCome & meet our amazing teamGenoskin at the SOT 65th Annual Meeting & ToxExpoDriving innovation in non-clinical toxicity assessment with ex vivo human skin and mast cell models We are pleased to announce that Genoskin will return to the SOT Annual Meeting and ToxExpo, taking place March 22–25, 2026, at the San Diego Convention Center in San Diego,
Read more
25
Sep

Media Kit

Media kit & brand assetsDownload Genoskin's media kit Get a copy of Genoskin's media kit. This document will provide you with all the information regarding Genoskin's activities, executive team and past media coverage. Please fill in the form below to access the media kit. Need more info? Please contact us! Contact us
20
May

WEBINAR #11 – From defense to disease: how Type 2 immunity shapes skin health

Top-level science through the eyes of an expert.Skin Deep: how microbes & immunity shape allergic reactionsDid you miss the live session? You can now watch the full webinar replay on demand where Dr. Phlipp Starkl explores how the skin’s immune system balances protection and pathology in response to microbial threats. In this webinar, Dr. Philipp Starkl shared his latest research
Read more
16
Oct

Genoskin awarded the Healthtech prize “Transformons la France!”

Genoskin awarded the Healthtech prize “Transformons la France!” Yesterday, Genoskin was awarded the Healthtech prize at the “Transformons la France!” (Let’s Transform France!) ceremony presented by La Tribune in Toulouse. While the current health crisis calls into question our lifestyles, "Transformons la France!" highlights the talents of tomorrow and gives impact to those who transform society for the better. The
Read more